The poll comes as U.S. obesity rates continue to pose a major health problem, leading to high rates of heart disease and diabetes.

Adult obesity rates in the United States dropped from 46% in 2022 to 45.6% in 2023, according to the new study published in ...

(HealthDay News) — The mean body mass index (BMI) and prevalence of obesity declined in the United States in 2023, according to research published in JAMA Health Forum.

Novo Nordisk NVO shares have plunged 17.9% in a week due to poorer-than-expected efficacy data from a late-stage study of its ...

Novo Nordisk on Friday revealed disappointing results in a late-stage trial for its experimental next-generation obesity drug ...

The updates from clinical trials of Eli Lilly's competitors in the obesity market were largely underwhelming this year. See ...

That’s a positive indicator, one doctor says, but developing healthier eating habits ‘would be much better than people just losing weight.’ ...

(Bloomberg Opinion) -- Housing market softness in the back half of 2018 has investors and the public wondering how bad things might get. It’s understandable that people would be worried,..

The study followed nearly 17 million people, the majority of whom were in the 26-75 age range, and found that after climbing ...

Additionally, the United States and several partner countries and organizations announced total investments of nearly USD 70 million to advance the Vision for Adapted Crops and Soils (VACS).

Results of the study indicate that Black women in the U.S., ages 66-75, saw the largest decrease in obesity between 2022-2023 ...

The secret agent in the decrease might be semaglutide, a GLP-1 receptor agonist that fuels popular weight loss drugs like ...